Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

1.

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Br J Psychiatry. 2008 May;192(5):338-43. doi: 10.1192/bjp.bp.107.037101.

PMID:
18450656
[PubMed - indexed for MEDLINE]
Free Article
2.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
[PubMed - indexed for MEDLINE]
3.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
[PubMed - indexed for MEDLINE]
4.

Serotonin reuptake inhibitor-induced perinatal complications.

Gentile S.

Paediatr Drugs. 2007;9(2):97-106. Review.

PMID:
17407365
[PubMed - indexed for MEDLINE]
5.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
[PubMed - indexed for MEDLINE]
6.

Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.

Fenger-Grøn J, Thomsen M, Andersen KS, Nielsen RG.

Dan Med Bull. 2011 Sep;58(9):A4303. Review.

PMID:
21893008
[PubMed - indexed for MEDLINE]
Free Article
7.

Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Eur J Clin Pharmacol. 2012 May;68(5):459-67. doi: 10.1007/s00228-011-1154-9. Epub 2011 Nov 13. Review.

PMID:
22080182
[PubMed - indexed for MEDLINE]
8.

Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?

Hanley GE, Oberlander TF.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):651-9. doi: 10.1002/bdra.23032. Epub 2012 Jun 26. Review.

PMID:
22733632
[PubMed - indexed for MEDLINE]
9.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
[PubMed - indexed for MEDLINE]
10.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
[PubMed - indexed for MEDLINE]
11.

Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.

Koren G, Boucher N.

Can J Clin Pharmacol. 2009 Winter;16(1):e66-7. Epub 2009 Jan 22. Review.

PMID:
19164848
[PubMed - indexed for MEDLINE]
Free Article
12.

Use of SSRIs in pregnancy: neonatal implications.

Courtney K.

Nurs Womens Health. 2009 Jun;13(3):234-8. doi: 10.1111/j.1751-486X.2009.01424.x. Review. No abstract available.

PMID:
19523137
[PubMed - indexed for MEDLINE]
13.

Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Drug Saf. 2011 Nov 1;34(11):1027-48. doi: 10.2165/11593130-000000000-00000. Review.

PMID:
21981432
[PubMed - indexed for MEDLINE]
14.

[Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].

Mejías C, Rodríguez-Pinilla E, Fernández Martín P, Martínez-Frías ML.

Med Clin (Barc). 2007 Apr 21;128(15):584-9. Review. Spanish.

PMID:
17462198
[PubMed - indexed for MEDLINE]
15.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
[PubMed - indexed for MEDLINE]
16.

[New antidepressive agents during pregnancy and lactation. Drug concentration should be monitored and the lowest possible dose administered].

Spigset O, Hägg S.

Lakartidningen. 2004 Mar 25;101(13):1176-81. Review. Swedish.

PMID:
15101242
[PubMed - indexed for MEDLINE]
17.
18.

To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects.

Austin MP.

Psychol Med. 2006 Dec;36(12):1663-70. Epub 2006 Jul 25. Review.

PMID:
16863595
[PubMed - indexed for MEDLINE]
19.

Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.

Nordeng H, Spigset O.

Drug Saf. 2005;28(7):565-81. Review.

PMID:
15963005
[PubMed - indexed for MEDLINE]
20.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

PMID:
18982836
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk